COMMUNIQUÉS West-GlobeNewswire

Vital Wound Care Launches AI-Driven Wound App and Expands In-Home Services Across Greater Houston
03/06/2025
New AI-powered app and biologic wound therapies bring hospital-grade care to homes across Greater Houston. Image by Vital Wound Care HOUSTON, June 03, 2025 (GLOBE NEWSWIRE) -- On May 1, Vital Wound Care introduced a [...]
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
03/06/2025
Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ≥5 years CARTITUDE [...]
Johnson & Johnson’s AKEEGA® (niraparib and abiraterone acetate dual-action tablet) is the first PARP inhibitor combo to show improved efficacy in patients with HRR-mutated mHSPC vs. current standard of care
03/06/2025
Results from the Phase 3 AMPLITUDE study show the potential of niraparib and abiraterone acetate to delay cancer progression and worsening of symptoms 1 Data show a nearly 50 percent reduction in disease progression in [...]
New analyses reinforce long-term benefit of DARZALEX® (daratumumab) subcutaneous-based quadruplet regimen for patients with newly diagnosed multiple myeloma
03/06/2025
Sustained MRD negativity (10 -5 ) rates at 24 months or longer were more than doubled in transplant eligible patients treated with daratumumab-VRd vs VRd alone in the Phase 3 PERSEUS study 1 Data from the Phase 3 [...]
Single infusion of CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) delivered lasting treatment-free remissions for at least five years in patients with relapsed or refractory multiple myeloma
03/06/2025
New long-term CARTITUDE-1 data show one-third of patients treated with cilta-cel remain progression-free at five years 1 CARTITUDE-4 analysis shows overall survival and progression-free benefits in standard and high- [...]
RESTEM to Present at the 2025 BIO International Convention
03/06/2025
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that Andres [...]
Conavi Medical Announces New Grant of Stock Options
03/06/2025
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“ Conavi Medical ” or the “ Company ”), announced that its board of directors (the “Board”) has approved grants of stock [...]
New Analysis of Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Published in Muscle and Nerve
03/06/2025
PRINCETON, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced the publication of a post-hoc analysis of data from the ERT-experienced cohort of the PROPEL study of [...]
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/06/2025
RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted seven newly-hired [...]
Vanqua Bio to Present at Upcoming Scientific Conferences
03/06/2025
CHICAGO, June 03, 2025 (GLOBE NEWSWIRE) -- Vanqua Bio , a clinical-stage biopharmaceutical company, announced that the company will present interim Phase 1 data for its lead clinical program, VQ-101, at two upcoming [...]
Kraig Biocraft Laboratories Issues a Letter to Shareholders on Recent Advancements and Potential Recombinant Spider Silk Deliveries in 2025
03/06/2025
ANN ARBOR, Mich., June 03, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, issues a letter to shareholders. Dear [...]
Cartesian Therapeutics Announces New Employment Inducement Grants
03/06/2025
FREDERICK, Md., June 03, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the [...]
Teva Announces Early Tender Results of its Debt Tender Offer, Increase to Tender Pool Caps and Total Maximum Amount and Election of Early Settlement
03/06/2025
TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“ Teva ”) announced today the early tender results in connection with its previously announced tender offers [...]
XPOLAR X Series: The Innovative Device Redefining Sports Recovery
03/06/2025
SHENZHEN, China, June 03, 2025 (GLOBE NEWSWIRE) -- XPOLAR, an innovator in sports recovery and wellness technology, officially debuted its X2 Recovery Device at CES 2025. Designed to meet the demand for smarter, more [...]
Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations
03/06/2025
Libby brings strong team building, growth, and sales operations and systems skills to Sanuwave after a career of growing startups into mid- and large-sized companies. EDEN PRAIRIE, Minn., June 03, 2025 (GLOBE NEWSWIRE [...]
Philanthropic Donor Funds Cognition Therapeutics’ Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
03/06/2025
Dr. James Galvin of the University of Miami to Serve as Lead Investigator First Site Initiated: Banner Sun Health Research Institute PURCHASE, N.Y., June 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “ [...]
Glass House Brands Announces June Investor Events
03/06/2025
LONG BEACH, Calif. and TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest- [...]
Le Bal Rouge de la Fondation du CUSM amasse 2,106,445 $ pour l’innovation en santé au CUSM
03/06/2025
MONTRÉAL, 03 juin 2025 (GLOBE NEWSWIRE) -- Le Bal Rouge, l’événement phare de la Fondation du CUSM, a réuni les leaders les plus passionnés du monde des affaires, de la philanthropie et de la santé pour célébrer une [...]
The MUHC Foundation’s Le Bal Rouge Gala raises $2,106,445 million for innovation in health care at the MUHC’s Glen site
03/06/2025
MONTREAL, June 03, 2025 (GLOBE NEWSWIRE) -- The MUHC Foundation’s signature gala, Le Bal Rouge , brought together Montreal’s most passionate changemakers in business, philanthropy and health care to celebrate a decade [...]

Pages